...
机译:细胞凋亡蛋白和肿瘤抑制基因的特异性递送组合癌症治疗
State Key Laboratory of Natural Medicines Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases Center of Advanced Pharmaceuticals and Biomaterials China Pharmaceutical University Nanjing 210009 China;
State Key Laboratory of Natural Medicines Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases Center of Advanced Pharmaceuticals and Biomaterials China Pharmaceutical University Nanjing 210009 China;
State Key Laboratory of Natural Medicines Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases Center of Advanced Pharmaceuticals and Biomaterials China Pharmaceutical University Nanjing 210009 China;
State Key Laboratory of Natural Medicines Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases Center of Advanced Pharmaceuticals and Biomaterials China Pharmaceutical University Nanjing 210009 China;
State Key Laboratory of Natural Medicines Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases Center of Advanced Pharmaceuticals and Biomaterials China Pharmaceutical University Nanjing 210009 China;
State Key Laboratory of Natural Medicines Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases Center of Advanced Pharmaceuticals and Biomaterials China Pharmaceutical University Nanjing 210009 China;
apoptosis; combination cancer treatment; drug delivery; liposomes; site-specific codelivery;
机译:细胞凋亡蛋白和肿瘤抑制基因的特异性递送组合癌症治疗
机译:基于纳米医生的组合癌症治疗的最近进展使用特定于特别的共同交付策略
机译:使用位点特异性共同交付策略的基于纳米医生的组合癌症治疗的最新进展
机译:Intein介导的抗MDR癌症治疗可活化蛋白质输送系统的特异性合成
机译:下一代癌症治疗的平台:用于位点特异性基因递送和表达的多目标非病毒载体。
机译:化学遗传学筛选确定靶向抗凋亡蛋白用于癌症治疗的激酶抑制剂组合。
机译:药物递送:依次特异性递送凋亡蛋白和肿瘤抑制基因的组合癌症治疗(小40/2019)
机译:乳腺癌的新酶前体和蛋氨酸 - 消耗组合疗法设计用于有效递送到肿瘤。